Summary by Futu AI
JUN SHENG TAI PHARMACEUTICAL-B (02511.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 5, 2024, REPORTING CHANGES IN COMPANY SHARES AS OF JANUARY 31, 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with 1,000,000,000 shares outstanding at the end of last month and deposits at the end of this month, with a face value of $0.0001 per share, and the total regulated/registered share capital remained at $100,000. IN ADDITION, STOCK OPTIONS, WARRANTS, CONVERTIBLE STOCK NOTES AND OTHER RELATED AGREEMENTS OR ARRANGEMENTS MENTIONED IN THE REPORT WERE UNCHANGED DURING THE MONTH. Dr. Liu Liping, the Executive Director and Chief Executive Officer of the Company, confirmed that all issuance of the securities has been approved by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.